Skip to search formSkip to main contentSkip to account menu

R 80122

Known as: Acetamide, N-cyclohexyl-N-methyl-2-(((phenyl(1,2,3,5-tetrahydro-2-oxoimidazo(2,1-b)quinazolin-7-yl)methylene)amino)oxy)-, (E)-, R-80122, R80122 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

ImidazolesQuinazolines
R 79595R 80123

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Hämodynamische Effekte verschiedener Dosierungen des Phosphodiesterase-III-Hemmers R80122
Zusammenfassung Selektive Phosphodiesterase(PDE)-III-Hemmer werden aufgrund ihrer inotropen, lusitropen und vasodilatatorischen… 
1999
1999
Hemodynamic effects of different doses of the phosphodiesterase-III-inhibitor R80122
Selective inhibitors of the phosphodiesterase isoenzyme III (PDE-III) are well known for the treatment of catecholamine-resistent… 
1995
1995
Hämodynamische Effekte neuerer Phosphodiesterase-III-Hemmer bei Patienten mit koronarer Herzkrankheit Ein Vergleich zwischen Enoximon und R80122
ZusammenfassungIn dieser Untersuchung wurden die hämodynamischen Effekte einer Bolusinjektion von 1,0 mg/kg KG Enoximon bzw. 0,3… 
1995
1995
[Hemodynamic effects of new phosphodiesterase inhibitors in patients with coronary heart disease. A comparison between enoximone and R80122].
At present, phosphodiesterase III inhibitors are commonly used for the treatment of low cardiac output states. Despite their… 
1995
1995
Hemodynamic effects of the novel selective cAMP-phosphodiesterase III inhibitor R 80122 in anesthetized patients with moderate left ventricular dysfunction before coronary artery bypass grafting.
1994
1994
The new phosphodiesterase inhibitor R80122 in comparison with enoximone
1994
1994
Peripheral and cardiac effects of a new phosphodiesterase inhibitor in comparison with enoximone.
The effect of the new phosphodiesterse inhibitor R80122 (E)-N-cyclohexyl-N-methyl-2-[[[phenyl(1,2,3,5-tetrahydro-2-oxoimidazo [2… 
1993
1993
Pharmacology of the selective phosphodiesterase-III inhibitor R-80122
1992
1992
In Vitro Pharmacology of R 80122, a Novel Phosphodiesterase Inhibitor
Summary: The cardiac in vitro effects of R 80122, a novel phosphodiesterase (PDE) inhibitor, were investigated and compared with… 
1992
1992
[Effects of R80122. The influence of a new phosphodiesterase inhibitor on global and intestinal hemodynamics in coronary surgery patients].
Phosphodiesterase III inhibitors have been established in recent years in the therapy of congestive heart failure. Many… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)